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The domestic dog represents an ideal model for identifying susceptibility genes, many of which are 
shared with humans. In this study, we investigated the genetic contribution to individual differences in 
40 clinically important measurements by a genome-wide association study (GWAS) in a multinational 
cohort of 472 healthy dogs from eight breeds. Meta-analysis using the binary effects model after 
breed-specific GWAS, identified 13 genome-wide significant associations, three of them showed 
experimental-wide significant associations. We detected a signal at chromosome 13 for the serum 
concentration of alanine aminotransferase (ALT) in which we detected four breed-specific signals. A 
large proportion of the variance of ALT (18.1–47.7%) was explained by this locus. Similarly, a single SNP 
was also responsible for a large proportion of the variance (6.8–78.4%) for other measurements such 
as fructosamine, stress during physical exam, glucose, and morphometric measurements. The genetic 
contribution of single variant was much larger than in humans. These findings illustrate the importance 
of performing meta-analysis after breed-specific GWAS to reveal the genetic contribution to individual 
differences in clinically important measurements, which would lead to improvement of veterinary 
medicine.
The domestic dogs share many diseases and phenotypes with human1. Through two bottlenecks resulting from 
domestication2 and the frequent use of specific males, each dog breed shows lower heterogeneity for disease. In 
humans, higher heterogeneity, meaning multiple variants with different levels of effects influencing the same 
disease, makes it difficult to identify genetic variants associated with disease3. Therefore, dogs are considered 
an ideal model animal for identifying genes and genomic loci underlying diseases and phenotypic variation1,4. 
Genome-wide association studies (GWAS) using canine single nucleotide polymorphism (SNP) chips have identi-
fied susceptibility genes and genomic loci for several complex diseases5–10 and for many Mendelian disorders11–16.
The diagnosis of a disease often involves taking many clinical measurements including blood and urine anal-
ysis. These measurements directly reflect different aspects of the health of each individual. Individual differences 
in these measurements are known to be heritable in humans, and GWAS have identified genetic loci explain-
ing these individual differences17. A systematic analysis of 6,046 dogs has identified breed-specific differences 
in hematological measurements18, suggesting also a genetic contribution to the inter-breed variation for these 
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measurements. Identification of the responsible genes would lead to a better understanding of the biological 
mechanism under the intermediate phenotypes for different diseases, which would improve veterinary medicine.
In this study, 40 clinically relevant measurements were collected from 472 dogs of eight different breeds in five 
countries. The measurements included 9 morphometric measurements, 4 urinary and 24 clinical blood parame-
ters, and 3 stress responses during the clinical exam (see Supplementary Table S1). We conducted breed specific 
GWAS and its meta-analysis with the 40 measurements in order to reveal the genetic contribution underlying 
individual differences.
Results
Breed-specific GWAS and meta-analysis. As shown in Supplementary Fig. S1, we showed a series of 
analyses conducted in this study. A total of 472 dogs were genotyped using a 170 K Illumina HD canine SNP 
array19 and 145,741 SNPs were selected after quality control (QC). We used the genome-wide efficient mixed 
model association (GEMMA) algorithm20 to perform association analyses of 301 combinations of phenotypes 
and breeds. We excluded 19 combinations due to missing phenotypes (Supplementary Table S1). The genomic 
inflation factor was 1.038 ± 0.006 (average ± standard error), suggesting that the algorithm was able to control 
for population structure. Supplementary Table S2 lists the seven genome-wide significant associations showing 
p < 5 × 10−7 determined by Bonferroni correction for the average number of common SNPs with minor allele 
frequency > 0.01 in each breed, although they did not show experimental wide significant association taking 301 
tests into consideration. Supplementary Fig. S2 shows the association between the genotypes of a lead SNP and 
the clinical measurements.
In order to integrate the results from all eight breeds, meta-analyses were performed using the binary effects 
model to account for the existence of genetic effect in each breed21. This model assumes that (1) the effect may 
be present in some and absent in others of the studied breeds and (2) if the effect exists in a breed, the effect size 
is similar between breeds. The inflation factor was 1.140 ± 0.009. After applying a genomic control correction, 
13 associations reached a genome-wide association level at p < 5 × 10−7 (Table 1). This number is much higher 
than expected under null hypothesis (2 = 40 × 0.05). The three associations for Alanine transaminase (ALT), 
fructosamine, and stress during physical examination reached an experiment-wide association level, accounting 
for multiple testing of the 40 phenotypes (p < 1.25 × 10−8).
Alanine transaminase: ALT. ALT level in blood is used for the diagnosis of liver disease and injury in 
human and veterinary medicine22. The strongest signal (p = 1.02 × 10−19, experimental-wise p ≪ 1 × 10−10) for 
ALT was observed at BICF2P496164 (chr13: 37,935,521 on CanFam3.1) and we did not observe significant asso-
ciation in the other chromosomes. Manhattan plot and QQ plot are shown in Fig. 1a and Supplementary Fig. S3a. 
A plausible functional candidate gene, GPT encoding ALT, is located in this locus. A causal variant linked with the 
associated SNP would increase expression level of GPT, which would lead to the production of more ALT protein. 
Figure 1b shows the local association profile (p-values for all SNPs in the region) for each breed at this locus (the 
BICF2P496164 ± 2 Mb), which differed among the eight breeds. Indeed, the m-values calculated by meta-analysis 
using the binary effects model21 (Table 1) suggest a genetic effect of BICF2P496164 in five breeds only: Belgian 
Shepherds, Cavalier King Charles Spaniel, Doberman, Finnish Lapphund, and Newfoundland (m-value > 0.9). 
To identify additional independent associations in this locus, conditional analyses were performed with the 
lead SNP (BICF2P496164) as a covariate. BICF2P518128 (chr13: 36,960,246) showed independent association 
(P = 1.81 × 10−5) which passed threshold at P = 2.89 × 10−4 considering multiple testing with 173 SNPs in this 
locus.
In order to calculate the contribution of this locus for each breed, we searched for the highest association of 
each breed separately. As shown in Fig. 1c, Belgian Shepherd and Cavalier King Charles Spaniel had lead SNPs 
that differed from the lead SNP in the meta-analysis (BICF2P496164) but they had very high linkage disequilib-
rium with BICF2P496164 (r2 > 0.973). They were considered as one signal. In Finnish Lapphund, BICF2P111900 
showed the highest association (P = 5.96 × 10−6) and moderate linkage disequilibrium with BICF2P496164 
(r2 = 0.481). We considered BICF2P111900 as another signal. In Newfoundland, TIGRP2P176579 (P = 5.22 × 
10−6) and TIGRP2P176993 (P = 1.91 × 10−4) showed independent associations and had low and moderate link-
age disequilibrium respectively with BICF2P496164 (r2 = 0.075 and 0.544) as shown in Supplementary Fig. S4. 
They were considered two additional independent signals. In total, we observed four breed-specific signals. 
SNP(s) in this locus explained from 18.1 up to 47.7% of the variance (Table 2) based on the highest association of 
each breed. Association between each lead SNP and ALT is shown in the Fig. 2.
Fructosamine. Fructosamine is a stable condensation product of glucose with serum proteins. It is used as 
a biomarker for diagnosing and managing diabetes because fructosamine reflects the average blood sugar con-
centration over the preceding 2 weeks23. The strongest signal (p = 2.21 × 10−11, experimental-wise p = 8.85 × 
10−5) was observed at BICF2P1369335 (chr17: 61,926,412). LELP1 is the only protein coding gene located in this 
region but its association with fructosamine is not reported. Manhattan plot and QQ plot are shown in Fig. 3a and 
Supplementary Fig. S3b, respectively. Figure 3b shows the distribution of p-values for each breed at this locus (the 
lead SNP ± 2 Mb). The m-value suggests genetic effects of this SNP in Finnish Lapphund, German Shepherd and 
Newfoundland (Table 1). Although conditional analysis did not show independent association in these breeds, 
a p-value of 4.16 × 10−5 was detected in Belgian Shepherd dogs at a different SNP (BICF2P218994), which was 
1 Mb from the lead SNP in the meta-analysis. Since linkage disequilibrium between BICF2P218994 and the lead 
SNP in the meta-analysis (BICF2P1369335) was low (r2 = 0.013), this is independent of the lead signal in the 
meta-analysis. This was also suggested by the M value of BICF2P1369335 in Belgium Shepherds (M = 0.000). 
Each lead SNP explained 11.2–45.8% of the variance as shown in Table 3. Figure 3c shows association between 
genotypes of each lead SNP and fructosamine.
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Stress during physical examination. We identified experiment wide significant association of stress dur-
ing physical examination (P = 8.25 × 10−9, experimental-wise p = 0.032) as shown in Table 1. The m-value sug-
gests that the same QTL effect segregates in Cavalier King Charles Spaniel (P = 2.95 × 10−6, m-value = 1.000) and 
Dachshund (P = 1.51 × 10−3, m-value = 0.997) at BICF2P1232291 (chr 1: 109,530,837). Supplementary Table S3 
show that in both breeds dogs with an A allele were considered to be more stressed during physical exam. There 
are no protein coding genes in this locus.
Morphometric measurements. In the meta-analyses on morphometric measurements (Table 1 and 
Supplementary Fig. S5), four genome-wide associations were identified for the morphometric measure-
ments C (height at withers), D (maximal chest diameter), and E (body length). Since they did not reach the 
experiment-wide significance level, a validation study with additional dogs is required. However, two regions, 
including LCORL on chromosome 3 and IGF1 on chromosome 15, have previously been identified as being asso-
ciated with breed differences in body size24. In the LCORL locus, the m-values calculated by the meta-analysis 
suggest that a genetic effect of this SNP exists only in Belgian Shepherd and German Shepherd. The SNP explained 
26.8 and 35.4% of the variance, respectively (Supplementary Table S4). The association between Morphometric 
parameter C (height at withers) and the lead SNP (BICF2G630361702) in the LCORL locus in different breeds 
showed a clear pattern (Supplementary Fig. S6a). The largest and smallest breeds are fixed for opposite alleles.
The pattern between Morphometric parameter E (body length) and BICF2P67088 at the IGF1 locus was less 
clear (Supplementary Fig. S6b) but the lead SNP was fixed to a C allele with a smaller value in the smallest breed, 
Phenotype SNP Chr Position P value
Experimental-
wise p
M value
Human
chr
Human
position 
(Mb)
Nearest 
geneBS CK DH DM FL GS LR NF
Alanine 
transaminase
BICF 
2P49 
6164
13 37,935,521 1.02E-19 ≪1E-10 1.000 1.000 0.047 1.000 0.959 0.686 0.884 1.000 8 145.7 GPT, RECQL
Fructosamine
BIC 
F2P1 
369335
17 61,926,412 2.21E-11 8.85.E-05 0.000 LowMAF LowMAF 0.062 0.949 1.000 0.000 0.999 1 153.2 LELP1
Stress during 
physical exam
BIC 
F2P1 
232291
1 109,530,837 8.25E-09 0.032 0.002 1.000 0.997 NoData 0.001 0.101 0.001 NoData 19 46.7 IGFL1
Morphometric 
parameter 
C (height at 
withers)
BICF 
2G63 
0361702
3 91,114,590 5.47E-08 0.196 1.000 LowMAF LowMAF LowMAF LowMAF 1.000 LowMAF 0.526 4 18.0 LCORL
Morphometric 
parameter 
C (height at 
withers)
BICF 
2S22 
921821
13 31,268,352 7.87E-08 0.270 0.003 0.097 0.987 0.861 0.903 0.999 0.999 0.376 8 136.3 KHDRBS3
C reactive protein
BICF 
2S236 
9445
31 15,294,994 1.76E-07 0.505 0.000 0.991 0.015 0.184 LowMAF 0.014 0.000 1.000 21 20.5
Erythrocytes
BICF 
2P75 
1898
32 14,312,867 2.49E-07 0.631 0.982 0.734 0.884 0.305 1.000 0.098 0.092 0.786 4 92.1 CCSER1
Morphometric 
parameter E 
(body length)
BICF 
2P67 
088
15 41,206,514 2.62E-07 0.649 0.003 LowMAF 1.000 0.501 0.753 LowMAF 0.996 0.201 12 102.8 IGF1
Glucose
BICF 
2S230 
23572
36 13,767,189 2.64E-07 0.652 0.999 0.653 0.811 0.700 1.000 0.870 0.926 0.819 2 169.8 ABCB11, G6PC2
Heart rate 
during clinical 
examination
BICF 
2P11 
78436
7 77,665,554 3.82E-07 0.783 0.219 0.991 1.000 0.249 0.287 LowMAF 0.257 NoData 4 110.6 CCDC109B
Stress during 
physical exam
BICF 
2G63 
0755819
36 28,527,094 4.25E-07 0.817 1.000 0.670 0.808 NoData 0.561 0.976 0.829 NoData 2 187.1
Morphometric 
parameter D 
(maximal chest 
diameter)
BICF 
2P200126 12 61,747,626 4.53E-07 0.837 0.001 LowMAF 0.983 0.534 0.004 0.720 1.000 0.499 6 104.7
Stress during 
physical exam
BICF 
 
0218038
17 13,896,382 4.61E-07 0.842 0.001 0.973 1.000 NoData 0.658 0.039 0.090 NoData 2 18.8 NT5C1B
Table 1. Significant associations in the trans-breed GWAS. Associations with p < 5 × 10−7 is shown. The 
experimental-wise p values were calculated by the Bonferroni correction with the number of SNPs (n = 100,000) 
and phenotypes (n = 40). Adjusted P value for Alanine transaminase was not precisely calculated because its 
value is too smalll. The m-value was obtained using the binary effects model with Metasoft21. The chromosome 
position is based on CanFam 3.1; m-values > 0.9 suggesting the existence of genetic effect are underlined. BS, 
Belgian Shepherd; CK, Cavalier King Charles Spaniel; DH, Dachshund; DM, Doberman; FL, Finnish Lapphund; 
GS, German Shepherd; LR, Labrador Retriever; NF, Newfoundland. “NoData” and “LowMAF” indicate no 
phenotypic data and an MAF < 0.05 in that breed. The corresponding chromosome position in humans was 
defined according to hg19.
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Figure 1. Results of a meta-analysis for ALT. (a) Manhattan plot of a meta-analysis (CanFam 3.1). (b) Local 
association profile for each breed covering 36–40 Mb of chromosome 13. The red line indicates p = 0.05. (c) 
Fig. 1c zoomed to the position 36–40 Mb of chromosome 13 in (a). Each dot shows the p value of the meta-
analysis. We searched for the highest association of each breed separately. The three breeds with black font 
shared the same association signal, although lead SNPs were different and had high linkage disequilibrium 
(r2 > 0.973) with the lead SNP of the meta-analysis (BICF2P496164). Finnish Lapphunds with red color had an 
independent association signal, and Newfoundlands had two independent association signals colored in green 
and blue, because BICF2P496164 did not have high linkage disequilibrium with their lead SNPs in each breed.
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the Cavalier King Charles Spaniel. In the Dachshund, we observed another SNP (BICF2P274829) 440 kb away 
from BICF2P67088 showing the highest association in this locus (p < 1.44 × 10−5). This SNP explained 68.1% 
of the variance in morphometric parameter E (body length) in Dachshunds. The length of the back in dogs with 
the GG genotype was 12.6% (5.9 cm) longer than that in dogs with the AA genotype (GG: 52.3 cm; AA: 46.4 cm, 
Supplementary Fig. S7).
Supplementary Table S4 and Supplementary Fig. S7 showed other associations between phenotypic values and 
genotypes of a lead SNP in significant loci identified in the meta-analyses.
Discussion
In this study, we collected 40 clinically relevant measurements from 472 healthy dogs of eight breeds, and per-
formed breed-specific GWAS and meta-analyses. In total, 13 genome-wide significant associations were iden-
tified in meta-analyses. This number was much higher than expected under the null hypothesis. We observed 
experiment-wise significant association for ALT, fructosamine, and stress during physical exam.
Of these, the strongest association was for ALT. This association has been reported in a GWAS with 353 dogs 
consisting of multiple breeds25. Taking advantage of the possibility to analyze each dog breed in our study, we 
investigated a lead SNP in each breed. We have identified four different signals (Fig. 1c). This locus in each dog 
breed contributed from 18.1% up to 47.7% of the variance of the enzyme range (Table 2). Since these lead SNPs 
most probably do not represent causative variants, as illustrated in human GWASs26, the contribution from this 
locus could even be greater. In humans, the heritability of ALT was estimated at 0.4827 and a GWAS of ALT using 
61,089 individuals have identified four loci28 but not the locus which corresponds to the canine locus identified 
here. In the human study, the effect size rather than the contribution was used as an indicator of the genetic 
effects of a single variant. The effect size for the four loci was 0.016‒0.060 in humans whereas it reached 1.08‒1.37 
in the five dog breeds from this study. Although effect size calculated from GWAS are known to be affected by 
a bias as “winner’s curse”, the change in the concentration of ALT per copy of each effect allele is roughly more 
than ten-fold higher in dogs than in humans. ALT is a liver specific cytosolic enzyme that is routinely screened 
for health assessment as a sensitive indicator for hepatocellular injury in dogs. Significant ALT variation exists 
among dog breeds29 and it would be important to know the contribution of a lead SNP in each breed to improve 
interpretation of ALT value in veterinary medicine especially in breeds predisposed to liver disease.
Individual differences in the level of fructosamine were mapped to chromosome 17. As in ALT, association 
was not found in all breeds but in only three of the studied breeds. One SNP in this locus also explained a large 
proportion (11.2–45.8%) of the variance. Note that the previous GWAS focusing on fructosamine data of the 
same dogs did not identify any genome wide significant associations29,30. This difference could be explained 
by different analyses methods. The previous study used linear mixed models including a fixed effect for breed, 
while here we normalized raw phenotype values to minimize the effect of outliers for statistical analysis, used the 
GEMMA algorithm in each breed separately, and merged p values by binary effects model to account for existence 
of genetic effect (see Materials and Methods). Note that using the same data, a genome wide significant associ-
ation on chromosome 3 (P = 1.68 × 10−6, P for permutation = 0.024) was reported in Belgium Shepherd30. In 
the current analysis, we observed a similar tendency, but it was not significant (P = 5.15 × 10−6). This divergence 
could be explained by different analysis methods and slight difference in the number of dogs (n = 118 in the pre-
vious analysis and n = 113 in this study).
We identified an experimental-wide association with stress during physical examination at chromosome 1. 
Two breeds, Cavalier King Charles Spaniels and Dachshunds, showed the same tendency. Dogs with the A allele 
of BICF2P1232291 showed more stress during physical examination. The research field of the genetics of dog 
behavior trait is of much interest, because dogs are unique animal models that can be used to understand behavio-
ral traits31. However, there are a limited number of studies32,33, because assessment of behavioral traits is a difficult 
task. In this study, we used subjective judgment from dog handlers. Although experienced dog handlers might 
provide better assessment than other behavioral tests, handler assessment should be replaced by a method to 
assess endophenotype, which has the potential to measure the same phenotype anywhere and to dissect behavior 
into biological response31.
A large contribution due to a single variant was also observed for other phenotypes. Since these associations 
should be validated by using independent samples, we only focus on associations that can be supported by addi-
tional evidence. Morphometric parameters C (height at withers) and E (body length) were mapped to regions 
close to LCORL and IGF1, respectively. These regions have already been reported to be associated with breed 
differences in body size19,24,34. The lead SNP reported here contributed to individual differences in morphometric 
Breeds SNP
Position (chr 
13) MAF Pvalue
Contribution 
(%)
Belgian Shepherd BICF2P595171 38,063,924 0.179 1.02.E-07 18.5
Doberman BICF2P496164 37,935,521 0.421 1.43.E-06 47.7
Newfoundland
TIGRP2P176579 37,865,275 0.095
5.93.E-04 18.1
TIGRP2P176993 39,050,399 0.369
Finnish Lapphund BICF2P111900 37,768,002 0.456 5.96.E-06 41.0
Cavalier King Charles 
Spaniel BICF2P242812 37,978,745 0.338 5.00.E-04 31.2
Table 2. Association between a lead SNP and the ALT level for each breed. There were two independent 
associations in Newfoundland.
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parameters in a few breeds only because it was fixed for the other allele in some breeds (Supplementary Fig. S6). 
Again the contribution of each SNP was larger than observed in human. Any one SNP associated with these mor-
phologic traits could explain 6.8–68.1% of the variance within a breed (Supplementary Table S4). In comparison, 
all 697 variants identified in the latest GWAS explain only ~16% of the phenotypic variance in human height35.
A large contribution of a single variant was also observed for the glucose level. Glucose serum level in this 
study was linked to a locus of chromosome 36 that corresponds to the locus associated with fasting plasma glu-
cose level in humans36, close to the gene G6PC2. G6PC2 encodes an enzyme that catalyzes the hydrolysis of 
glucose-6-phosphate, allowing the release of glucose into the bloodstream. While homozygotes of either allele 
showed differences of only 2.7% in glucose level (5.24 and 5.10 mmol/l) in humans, they showed differences of 
26.6% (1.067 and 0.843 mmol/l) in Finnish Lapphund dogs. Further study is needed to reveal if this SNP influ-
ences susceptibility for diabetes.
This study has three main implications for canine GWAS. (1) International collaboration for sampling allows 
increasing the number of dogs to get a higher statistical power. However, although we have collected phenotypes 
from the same breed with the same sex in neighboring countries we have observed clear differences in the pheno-
types (Supplementary Fig. S8 for female Labrador Retriever and S9 for male Belgian Shepherd). Environmental 
effects, diagnostic procedure, breeding selection for specific purpose37, or other unrecognized phenotyping 
biases, can cause this kind of “group effect”38. So we had to normalize data within each group instead of merging 
the original phenotyping data from different groups to avoid this bias of “group effect”. (2) GWAS using dogs of 
different breeds25,39,40 can efficiently map the chromosome region associated with a phenotype. However, the 
association identified by this kind of analysis is not always applicable to all breeds. Indeed, an association between 
height and the LCORL locus was found by GWAS using dogs of different breeds24 but in our study the lead SNP 
contributed to individual difference only in 2 of 8 breeds and the allele was not polymorphic in four breeds. 
The same is true for ALT, fructosamine and other phenotypes. Therefore, in the context of a genetic marker for 
the improvement of veterinary medicine, the identification of SNPs for individual differences rather than breed 
differences is important. It is necessary to analyze the association in each dog breed using a sufficient number of 
dogs. (3) In this study, we identified three experiment-wide significant associations whose SNPs explained a much 
larger part of the variance than that in humans. However, the current number of dogs might not have had enough 
power to identify other associations with smaller effect sizes. Supplementary Table S5 shows the results of a power 
calculation to have genome wide significance at P = 5 × 10−7 under different scenarios of effect size (0.01–1.5) 
and total sample size (50 – 10,000) with GPower 3.141. The total number of dogs in this study (n = 472) was 
enough for sufficient statistical power to identify the strongest signal for ALT, because its effect size was 1.08–1.37. 
However, when effect size is 0.5, for example, we need more than 1,000 dogs, and the current number of dogs is 
not enough for sufficient statistical power. Therefore, we need more dogs, or we need to perform a meta-analysis 
with other studies examining the same phenotypes in order to identify weaker associations.
Figure 2. Association between the ALT values and genotypes of a lead SNP in each breed. The number of dogs 
for each genotype is shown in parenthesis.
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In summary, the meta-analyses enabled the identification of 13 genome-wide associations for clinical meas-
urements. Most of the associated phenotypes were strongly controlled by only one or two genetic variants at 
a single locus. The genetic effect of a single variant was much larger than in humans. This study illustrates the 
importance of performing meta-analysis after breed-specific GWAS to reveal genetic contribution to individual 
differences in clinical measurements, which would lead to improvement of veterinary medicine.
Figure 3. Results of a meta-analysis for fructosamine. (a) Manhattan plot of a meta-analysis (CanFam 3.1). (b) 
Local association profile for each breed covering 60–64 Mb of chromosome 17. The red line indicates p = 0.05. 
(c) Association between the frutosamine level and genotypes of a lead SNP in each breed. The number of dogs 
for each genotype is shown in parenthesis.
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Methods
Dogs. A total of 472 healthy dogs consisting of eight breeds (Belgian Shepherd, Cavalier King Charles Spaniel, 
Dachshund, Doberman, Finnish Lapphund, German Shepherd, Labrador Retriever, and Newfoundland) from 
five countries (Belgium, Denmark, Finland, France, and Sweden) were recruited for this study as part of the 
EU-funded LUPA project (Supplementary Table S6)42. Our group previously reported GWAS focusing only on 
fructosamine using the same dogs30. However, using the binary effects model that was expected to increase the 
statistical power of the analysis, we have obtained a new association regarding fructosamine that is worth being 
reported in the present study.
To be included in the study, dogs had to be pure-bred, healthy and between 2 and 7 years of age with a normal 
body condition score. Dogs could not be related to each other at the parental level. Within each group and each 
breed, dogs had to be of the same sex; females were in anoestrus or spayed, males were intact. Exclusion criteria 
consisted of any finding indicating systemic or organ-related disease in the history, physical examination, blood 
work or urinalysis described below.
Clinical data collection. We collected 40 clinical relevant measurements as shown in Supplementary 
Table S1. All dogs were examined fasted (12 hours for food and 2 hours for water). A complete history was taken 
and each dog underwent a thorough physical examination. During this physical exam several morphometric 
parameters and stress responses were measured as well. Stress phenotype was assessed by the same dog handler 
within each country (5 dog handlers in total) using the same 4-criteria scale (stress absent, mild stress, moderate 
stress and heavy stress). This scale was subjective, and though handler differences were not controlled, all of them 
were experienced vets that were used to interact with dogs. Furthermore, within breeds, the same handler per-
formed the tests on all dogs, except for Labradors and Belgian Shepherds, which were shared between different 
dog handlers.
Blood were taken to perform routine analysis, as well as to measure cardiovascular hormones and biochem-
ical parameters related to metabolic syndrome. Urine sample was collected by voiding on each dog. Blood sam-
pling was carried out by venipuncture and blood was collected into EDTA and serum tubes. Routine analysis 
of hematology and biochemistry including total protein, parameters of liver and kidney function and serum 
electrolyte concentrations were performed. Standard urine analysis was performed by dipstick chemistry test 
and refractometer for urine specific gravity. Serum was collected to measure parameters related to lipid (free fatty 
acid, cholesterol, triglycerides and C reactive protein) and carbohydrate metabolism (glucose, fructosamine and 
insulin), as well as cortisol level. Plasma was collected to measure cardiovascular hormones (endothelin-1, aldos-
terone, plasma renin activity, NT-proANP and NT-proBNP). Tubes were centrifuged within 30 minutes of blood 
sample collection. Plasma and serum were harvested, transferred into plastic cryotubes and samples were frozen 
and stored at −80 °C. All samples were later transported frozen to different accredited laboratories. All analyses 
were performed using commercially available assays validated for dogs, according to manufacturers’ instructions. 
Insulin, cortisol and cardiovascular hormones samples were analyzed in duplicate by personnel blinded to dog 
identity, and the mean of the two results was used for data analysis. Data were tested for normality using Shapiro 
Wilk test. Outliers were individually checked and some of them were excluded from the analysis if their results 
seemed inappropriate.
Descriptive statistics for the 40 phenotypes are listed in Supplementary Table S1. As breed differences for some 
phenotypes have been reported elsewhere43,44, breed and sex differences for these phenotypes were expected. 
But we have also observed differences between countries where Labrador retriever and Belgian Shepherd were 
sampled. Among the 35 phenotypes collected in female Labrador Retrievers in Denmark and France significant 
differences were observed in 10 phenotypes (p < 1.43 × 10−3 = 0.05/35) as shown in the Supplementary Fig. S8. 
Similarly 18 of 36 phenotypes showed significant differences (p < 1.39 × 10−3 = 0.05/36) between Belgium and 
France for male Belgian Shepherds (Supplementary Fig. S9). Therefore, we decided to normalize phenotype data 
within each group based on country, breed, and sex before GWAS to eliminate these kinds of group effects.
We converted a raw value to a relative rank within each dog group for the following investigations for the 
purpose of conducting nonparametric analyses of the phenotypic data. To calculate the relative rank of each phe-
notype within each dog group, each dog was assigned a rank, which was divided by the number of dogs in that 
group. The relative rank was thus between 0 and 1.
Genotyping. Genotypic analyses were conducted using 472 dogs with a 170 K Illumina canine HD SNP 
array19. The CanFam 3.1 reference sequence was used. The QC process eliminated 38,725 SNPs due to a low call 
rate (<95%), low minor allele frequency (MAF) (<0.01), and deviation from Hardy-Weinberg equilibrium (p < 1 
× 10−6 for each breed). Finally, 145,741 SNPs were analyzed in this study.
A total of 56,811 SNPs with an MAF > 0.2 and mutual r2 < 0.5 according to the indep-pairwise function in 
PLINK 1.0745 (–indep-pairwise 1000 100 0.5) were selected for principal component analysis (PCA). The analysis 
Breeds SNP
Position (chr 
17) MAF Pvalue
Contribution 
(%)
Belgian Shepherd BICF2P218994 62,923,275 0.4878 4.16.E-05 11.2
Finnish Lapphund BICF2G630286241 60,538,765 0.1556 0.013 12.2
German Shepherd BICF2P1369335 61,926,412 0.3367 7.34.E-07 45.8
Newfoundland BICF2P1369335 61,926,412 0.1548 5.32.E-04 31.5
Table 3. Association between a lead SNP and the fructosamine level for each breed.
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was performed using Eigenstrat 5.0.146 to check outliers inconsistent with the recorded dog breeds. A PCA did 
not reveal any outliers that were inconsistent with the recoded dog breeds (Supplementary Fig. S10).
Breed-specific GWAS and meta-analysis. Before GWAS, we adjusted confounding effects of breed and 
sex by normalizing phenotypes separately within each breed and sex. In GWAS, we did not include any covari-
ates. The GEMMA algorithm was applied to perform association analyses for a single phenotype in each breed 
accounting for population stratification20. The genomic inflation factor (λ) was defined as the ratio of the median 
of the observed test statistic to the expected median. When λ > 1, population stratification was suggested. We 
divided the test statistic of each SNP by λ as a corrected test statistic and recalculated a corrected P value as a 
genomic control correction. We set threshold for genome wide significance at p = 5 × 10−7 because there were 
103,740 common SNPs in each breed on average. The contribution of a single variant to explain the variance of 
each relative rank was calculated47. This method provides a bias-corrected estimate of the proportion of pheno-
typic variance.
A meta-analysis was also performed to integrate the p-values from the eight breeds for each phenotype. This 
analysis is similar to a trans-ethnic GWAS of humans that was used to examine several complex diseases such as 
type 2 diabetes48. A new framework, the binary effects model, was developed to account for the existence of effect 
to improve the statistical power as compared with fixed effects and random effects models21. This model also pro-
vides the posterior probability that the effect could exist in each breed as an m-value. An m-value > 0.9 suggests 
existence of a genetic effect in that breed.
We used the Metasoft ver. 2.01 to combine the association results in each breed with the binary model. The 
binary effects model was applied to the 40 phenotypes with SNPs with MAF ≥ 0.05 in two or more breeds. When 
the genomic inflation factor was >1, a genomic control correction was applied. The same threshold at p = 5 × 
10−7 was used for genome-wide significance, and p = 1.25 × 10−8 (= 5 × 10−7/40) was defined as the threshold 
value for experiment-wide significance. Since the lead SNP in a meta-analysis does not always show the highest 
association in a breed-specific GWAS, the best association was selected within ±2 Mb of a lead SNP for each dog 
breed. The regional association threshold was set by Bonferroni correction using the number of SNPs in that 
locus. We investigated independence between the lead SNP in the meta-analysis and the lead SNP in each breed 
by the calculation of r2 in each breed separately.
Ethics statement. This was already described in the previous paper30. The study was carried out in accord-
ance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National 
Institutes of Health and approved by an ethical Committee in Belgium (Commission d’Ethique Animale, 
Université de Liegè, Belgium, permit number 754), Sweden (Uppsala Local Ethical Committee, Uppsala, Sweden, 
permit number C 115/8), Finland (Viikki Campus Research Ethics Committee, Helsinki, Finland, no approval 
number used by committee) and Denmark (Local Ethical Committee, University Hospital for Companion 
Animals, Copenhagen, Denmark, at the time of the approval, the committee did not operate with approval 
numbers). In France, data was obtained before the creation of the Local Ethical Committee dedicated to clinical 
research (ComERC-ENVA). As the data were from client owned dogs undergoing normal veterinary exams, there 
was no animal experiment according to legal definitions in France. However, all local regulations related to clini-
cal procedures were observed. In all countries, informed owners consent was obtained for use of samples and data 
for scientific research. All undertaken procedures were part of routine veterinary clinical exam in all countries 
and the local responsible co-investigator, who was also licensed to practice veterinary medicine within the EU, 
was responsible for collection of the samples.
Data availability
All genotyping data was deposited in DRYAD (https://datadryad.org/stash/dataset/doi:10.5061/dryad.ft6fv).
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